238 related articles for article (PubMed ID: 23708661)
1. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
2. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
3. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ
Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904
[TBL] [Abstract][Full Text] [Related]
5. Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.
Zhang G; Tsang CM; Deng W; Yip YL; Lui VW; Wong SC; Cheung AL; Hau PM; Zeng M; Lung ML; Chen H; Lo KW; Takada K; Tsao SW
PLoS One; 2013; 8(5):e62284. PubMed ID: 23658720
[TBL] [Abstract][Full Text] [Related]
6. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.
Tsang CM; Cheung YC; Lui VW; Yip YL; Zhang G; Lin VW; Cheung KC; Feng Y; Tsao SW
BMC Cancer; 2013 Dec; 13():619. PubMed ID: 24380387
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
[TBL] [Abstract][Full Text] [Related]
8. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
9. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
[TBL] [Abstract][Full Text] [Related]
10. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
[TBL] [Abstract][Full Text] [Related]
12. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
Ou H; Li Y; Kang M
PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
[TBL] [Abstract][Full Text] [Related]
14. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.
Zhang X; Yang J; Bian Z; Shi D; Cao Z
Biomed Pharmacother; 2019 May; 113():108713. PubMed ID: 30849642
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
17. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
[TBL] [Abstract][Full Text] [Related]
18. EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway
Tung KL; Wu YT; Liu C; Lin SC; Wu CH; Wu SY; Chang Y; Lan YY
Anticancer Res; 2020 Jun; 40(6):3255-3264. PubMed ID: 32487620
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
Jiang L; Wang P; Chen L; Chen H
Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
[TBL] [Abstract][Full Text] [Related]
20. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
